Editor’s Note – Updated July 2025: This article was originally published in 2016. A 2024 study has been added to reflect ongoing interest in the combined use of chromium and magnesium to support insulin resistance and metabolic health.
08 Sep 2016
Combining oral supplementation with chromium and magnesium improves insulin resistance more effectively than either substance alone, according to new data.
Key highlights:
Evidence continues to support the complementary role of chromium and magnesium in supporting insulin sensitivity and metabolic health.
A 2024 randomised controlled trial found co-supplementation improved glycaemic control, lipid profiles, inflammation, and oxidative stress markers.
This study reinforces the value of targeted nutrient combinations in managing cardiometabolic risk factors.
Read on to explore the latest research evidence and clinical prescribing considerations for this nutrient combination in metabolic health support.
Not a member yet? Join now for free access to this article and more.
×
To continue reading this article, please
Log In or
Sign Up for access.